BP
CVS icon

BNP Paribas’s CVS Health CVS Stock Holding History

BNP Paribas’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.15M Buy
49,971
+25,617
+105% +$2.29M 0.14% 90
2026
Q1 		$1.75M Buy
24,354
+14,130
+138% +$1.09M 0.06% 152
2025
Q4 		$811K Buy
10,224
+7,624
+293% +$601K 0.02% 190
2025
Q3 		$196K Buy
2,600
+1,600
+160% +$110K 0.01% 217
2025
Q2 		$69K Hold
1,000
– – ﹤0.01% 257
2025
Q1 		$67.8K Sell
1,000
-600
-38% -$35.9K ﹤0.01% 259
2024
Q4 		$71.8K Buy
1,600
+700
+78% +$39.3K ﹤0.01% 276
2024
Q3 		$56.6K Sell
900
-100
-10% -$5.83K ﹤0.01% 269
2024
Q2 		$59.1K Sell
1,000
-4,584
-82% -$287K ﹤0.01% 256
2024
Q1 		$445K Buy
+5,584
New +$427K 0.02% 208

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BNP Paribas's CVS Position: Q2 2026 in Review

BNP Paribas increased its CVS Health (CVS) stake by 105% in Q2 2026, buying an estimated $2.29M and bringing the position to 49,971 shares worth $5.15M. The position accounts for 0.14% of the portfolio, ranked #90.

BNP Paribas first reported a position in CVS in Q1 2024 and has held it in 10 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • BNP Paribas held 49,971 shares of CVS Health worth $5.15M as of Q2 2026.
  • BNP Paribas bought 25,617 CVS Health shares in Q2 2026, an estimated $2.29M.
  • CVS Health made up 0.14% of BNP Paribas's portfolio in Q2 2026, its #90 holding.
  • BNP Paribas first reported a position in CVS Health in Q1 2024 and has held it in 10 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.